Erratum to 'Gökbuget N, Dombret H, Bonifacio M, et al. Blinatumomab for minimal residual disease in adults with B-cell precursor acute lymphoblastic leukemia'[Blood. 2018;131(14):1522-1531]
(2019) Blood — Vol. 133, n° 24, p. 2625 (2019)
Files
2019_Gökbuge_Blood_PMC.pdf
PMC
Open Access - Adobe PDF
- 267.85 KB
Details
- Authors
- Abstract
- On page 1526 of the 5 April 2018 issue, the scale of Figure 3B’s y-axis is inaccurate. The corrected Figure 3B is shown below. The error has been corrected in the online version of the article.
- Affiliations
Citations
Gökbuget, N., Dombret, H., Bonifacio, M., Reichle, A., Graux, C., Faul, C., Diedrich, H., Topp, M. S., Brüggemann, M., Horst, H.-A., Havelange, V., Stieglmaier, J., Wessels, H., Haddad, V., Benjamin, J. E., Zugmaier, G., Nagorsen, D., & Bargou, R. C. (2019). Erratum to ‘Gökbuget N, Dombret H, Bonifacio M, et al. Blinatumomab for minimal residual disease in adults with B-cell precursor acute lymphoblastic leukemia’[Blood. 2018;131(14):1522-1531]. Blood, 133(24), 2625. https://doi.org/10.1182/blood.2019001109 (Original work published 2019)